Chromatography
High Capacity Electrochemical Hplc Systems Enable Easy Compound and Oxidative-metabolite Synthesis
Oct 30 2007
At the systems' core are new, high-efficiency, high-capacity electrochemical-synthesis cells. Since the user can control the systems' oxidation capability to generate specific, desired oxidation products, they have wide utility in a variety of metabolite-generation tasks, alleviating the need to deploy precious medicinal chemistry resources to support drug-metabolism identification, while enhancing the synthesis capabilities of any laboratory.
ESA's new electrochemical synthesis systems are an ideal complement to LC-MS for ADME-Tox / DMPK and other drug-metabolism operations, because they can be used to quickly and easily generate large quantities of oxidative metabolites from parent compounds. Of particular interest to scientists evaluating the metabolic properties and toxicity of potential drugs, these systems mimic much of the oxidation capabilities of cytochrome P450, a key enzyme family that is responsible for metabolising most drugs. Drug interactions involving the cytochrome p450 system are common, and a major cause of attrition in the drug-development process. Understanding the metabolites generated by these enzymes is key to understanding a compound's metabolic fate.
ESA has designed two new synthesis cells to suite specific application needs. The 5150 cell has high capacity and is preferred for low-potential (
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
Apr 22 2024 Marrakech, Morroco
Making Pharmaceuticals Exhibition & Conference
Apr 23 2024 Coventry, UK
Apr 23 2024 Kintex, South Korea
Apr 23 2024 Seoul, South Korea
Apr 24 2024 Jakarta, Indonesia